國立虎尾科技大學 |

Biology and Treatment of Leukemia and Bone Marrow Neoplasms

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Biology and Treatment of Leukemia and Bone Marrow Neoplasms / edited by Vinod Pullarkat, Guido Marcucci.
其他作者:	Pullarkat, Vinod.
面頁冊數:	VIII, 196 p. 17 illus., 14 illus. in color.online resource. :
Contained By:	Springer Nature eBook
標題:	Hematology. -
電子資源:	https://doi.org/10.1007/978-3-030-78311-2
ISBN:	9783030783112

Biology and Treatment of Leukemia and Bone Marrow Neoplasms
Biology and Treatment of Leukemia and Bone Marrow Neoplasms [electronic resource] /edited by Vinod Pullarkat, Guido Marcucci. - 1st ed. 2021. - VIII, 196 p. 17 illus., 14 illus. in color.online resource. - Cancer Treatment and Research,1812509-8497 ;. - Cancer Treatment and Research,165.

Advances in diagnosis and risk stratification of leukemias and bone marrow neoplasms -- Genetics and diagnostic approach to lymphoblastic leukemia -- Acute promyelocytic leukemia: update on risk stratification and treatment -- Current and emerging therapies for AML -- Current management and new developments in treatment of ALL -- Contemporary therapy of CML -- MDS: Pathogenesis and therapy -- Chronic lymphocytic leukemia: Biology and therapy -- Biology and current treatment of Myeloproliferative neoplasms -- Systemic Mastocytosis: Pathology and treatment -- Adoptive T-cell therapy and other novel immunotherapies for leukemia.

This book provides a concise update on current understanding of the biology of acute and chronic leukemias and other bone marrow neoplasms, including myelodysplastic and myeloproliferative disorders, and explores new and emerging treatments. There is a particular focus on the molecular abnormalities that are drivers of leukemia and on their detection by modern molecular techniques. Knowledge of the ways in which genomic and metabolic abnormalities in the hematologic neoplasms affect prognosis and treatment decision making is reviewed. Detailed attention is devoted to targeted therapies, including novel drugs, and to potential targets for future drug development. In addition, readers find in-depth discussion of cellular and antibody-based immunotherapies as well as the role of hematopoietic stem cell transplantation in the treatment of leukemias and bone marrow malignancies. The book is of special interest for hematologists, oncologists, and cancer researchers; it is also of value for hematology trainees and medical students.

ISBN: 9783030783112

Standard No.: 10.1007/978-3-030-78311-2doiSubjects--Topical Terms:

645254
Hematology.

LC Class. No.: RB45

Dewey Class. No.: 616.15

Biology and Treatment of Leukemia and Bone Marrow Neoplasms
LDR:03090nam a22004095i 4500 001 1055935
003 DE-He213
005 20211009080548.0
007 cr nn 008mamaa
008 220103s2021 sz | s |||| 0|eng d
020 $a 9783030783112 $9 978-3-030-78311-2
024 7 $a 10.1007/978-3-030-78311-2 $2 doi
035 $a 978-3-030-78311-2
050 4 $a RB45
072 7 $a MJF $2 bicssc
072 7 $a MED038000 $2 bisacsh
072 7 $a MJF $2 thema
082 0 4 $a 616.15 $2 23
245 1 0 $a Biology and Treatment of Leukemia and Bone Marrow Neoplasms $h [electronic resource] / $c edited by Vinod Pullarkat, Guido Marcucci.
250 $a 1st ed. 2021.
264 1 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2021.
300 $a VIII, 196 p. 17 illus., 14 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
490 1 $a Cancer Treatment and Research, $x 2509-8497 ; $v 181
505 0 $a Advances in diagnosis and risk stratification of leukemias and bone marrow neoplasms -- Genetics and diagnostic approach to lymphoblastic leukemia -- Acute promyelocytic leukemia: update on risk stratification and treatment -- Current and emerging therapies for AML -- Current management and new developments in treatment of ALL -- Contemporary therapy of CML -- MDS: Pathogenesis and therapy -- Chronic lymphocytic leukemia: Biology and therapy -- Biology and current treatment of Myeloproliferative neoplasms -- Systemic Mastocytosis: Pathology and treatment -- Adoptive T-cell therapy and other novel immunotherapies for leukemia.
520 $a This book provides a concise update on current understanding of the biology of acute and chronic leukemias and other bone marrow neoplasms, including myelodysplastic and myeloproliferative disorders, and explores new and emerging treatments. There is a particular focus on the molecular abnormalities that are drivers of leukemia and on their detection by modern molecular techniques. Knowledge of the ways in which genomic and metabolic abnormalities in the hematologic neoplasms affect prognosis and treatment decision making is reviewed. Detailed attention is devoted to targeted therapies, including novel drugs, and to potential targets for future drug development. In addition, readers find in-depth discussion of cellular and antibody-based immunotherapies as well as the role of hematopoietic stem cell transplantation in the treatment of leukemias and bone marrow malignancies. The book is of special interest for hematologists, oncologists, and cancer researchers; it is also of value for hematology trainees and medical students.
650 0 $a Hematology. $3 645254
650 0 $a Oncology . $3 1253469
650 0 $a Medicine. $3 644133
650 2 4 $a Oncology. $3 593951
650 2 4 $a Biomedicine, general. $3 1253757
700 1 $a Pullarkat, Vinod. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1361232
700 1 $a Marcucci, Guido. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1361233
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9783030783105
776 0 8 $i Printed edition: $z 9783030783129
776 0 8 $i Printed edition: $z 9783030783136
830 0 $a Cancer Treatment and Research, $x 0927-3042 ; $v 165 $3 1254896
856 4 0 $u https://doi.org/10.1007/978-3-030-78311-2
912 $a ZDB-2-SME
912 $a ZDB-2-SXM
950 $a Medicine (SpringerNature-11650)
950 $a Medicine (R0) (SpringerNature-43714)